News

Naoki Okada, CEO of Fcuro Inc., to Speak at the 9th Medical Automation Research Meeting
2024.11.28
chevron_right
Shusuke Inoue, CTO of Fcuro Inc., to Speak at 「Hack Osaka2024 ~Link Innovation to Our Future~」
2024.11.28
chevron_right
fcuro is selected as Acceleration program “SCAP” assisting startups in expanding business overseas intensively.
2022.09.15
chevron_right
fcuro is selected as a participant company of the supporting program for international cooperation in Aichi-Nagoya Acceleration Project for International Cooperation -BEYOND-.
2022.08.02
chevron_right
Our activity is featured on Link-J’s webpage.
2022.07.04
chevron_right
Our project is selected for “Project Planning for the Demonstration and Introduction of Key Technologies for the Realization of the New Normal” by Mitsubishi Research Institute, Inc.
2022.06.30
chevron_right
CTO Shusuke Inoue gives a presentation at The 8th Annual Congress of the Japan Society of Clinical Safety.
2022.06.11
chevron_right
Our project is selected for “FY2022 AMED Medical Innovation Promotion Project (Development and Commercialization Project) , Venture Development”.
2022.04.22
chevron_right
fcuro wins the award for best pitch at “BRAVE 2021 DEMO DAY”, a pitch competition for next-generation deep tech entrepreneurs
2021.12.23
chevron_right
CEO Naoki Okada gives a presentation at a symposium for the study of AI in acute medicine in “The 49th Annual Meeting of the Japanese Association for Acute Medicine”.
2021.11.21
chevron_right
fcuro exhibits projects at Bio Japan 2021.
2021.10.21
chevron_right
fcuro signs a joint research agreement with Osaka General Medical Center.
2021.06.09
chevron_right
Our project is selected for “Project Planning for the Demonstration and Introduction of Key Technologies for the Realization of the post-pandemic era” by Mitsubishi Research
2021.05.27
chevron_right
fcuro signs a joint research agreement with Shizuoka Saiseikai General Hospital.
2021.03.26
chevron_right
CEO Naoki Okada gives a lecture at The 48th Annual Meeting of the Japanese Society of Intensive Care Medicine.
2021.02.14
chevron_right
Our joint research project with Osaka General Medical Center is selected for a recommended AI-research by the Japanese Association for Acute Medicine.
2021.01.01
chevron_right
Our project is selected for “COVID-19 AI & Simulation Project” by Cabinet Secretariat.
2020.12.04
chevron_right
Our project is selected for “FY2020 NEDO Entrepreneurs Program”.
2020.10.01
chevron_right
CEO Naoki Okada and CTO Inoue are selected for the “FY2020 Mitou Advanced Project” by IPA (Information-technology Promotion Agency).
2020.07.06
chevron_right
CEO Naoki Okada is selected for “The first Mitou AI Frontier Project”, and is awarded AI frontier pathfinder (acute medicine).
2020.02.21
chevron_right